olivLaw · US equity research
Flexible Solutions International, Inc. FSI
Miscellaneous Chemical Products · SIC 2890 · Vertical: Miscellaneous Chemical Products (SIC 2890)
Flexible Solutions International makes biodegradable polymers, water-treatment specialty chemicals and food-grade products used in the oil, agriculture and swimming pool industries. The company depends heavily on a small number of customers, and in 2026 its sales mix shifted as a new Panama plant and food-grade customer came online, with three primary customers accounting for 54% of sales in the June 2026 quarter.
At the close of 04 Nov 2026, Flexible Solutions International, Inc. (FSI) stock was 6.27 USD (+1.95% on the day), with market capitalisation 80.1 m USD, dividend yield 1.59%, beta 0.95, 52-week range 4.90–8.58 USD. Latest reported quarter (Q2 2026): revenue of 7.6 m USD (−33.1% YoY), net income of -1.9 m USD (−194.3% YoY), diluted EPS -0.15 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 55.4
- strong (55–70)
- Bollinger (20, 2)
- 5.93 – 6.48
- in the upper half of the band · %B 0.61 · band width 8.9%
- SMA 50 / 200
- 5.99 / 5.87
- uptrend (price > SMA50 > SMA200)
- MACD (12, 26, 9)
- 0.08 / 0.10
- MACD below signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | +2.5% | −1.1% | +3.5 pp | — |
| 3 months | +24.2% | −0.5% | +24.6 pp | — |
| 6 months | +1.1% | +4.4% | −3.3 pp | — |
| Year to date | −6.8% | +12.3% | −19.1 pp | — |
| 1 year | −29.1% | +13.5% | −42.6 pp | +19.0% |
| 3 years | +226.6% | +76.4% | +150.2 pp | −1.1% |
| 5 years | +75.6% | +63.7% | +12.0 pp | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q2 2026 · 30 Jun 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.3 m | 9.2 m | 7.5 m | 11.4 m | 10.6 m | 9.1 m | 8.3 m | 7.6 m |
| Cost of revenue | 5.5 m | 6.5 m | 5.5 m | 6.0 m | 8.0 m | 6.4 m | 6.4 m | 7.9 m |
| Gross profit | 3.8 m | 2.7 m | 2.0 m | 5.4 m | 2.5 m | 2.7 m | 1.9 m | -287.8 k |
| Research & development | 27.8 k | 113.0 k | 106.8 k | 167.2 k | 255.7 k | 85.6 k | 116.5 k | 107.9 k |
| SG&A | — | — | 756.1 k | 834.1 k | — | — | 762.4 k | 532.6 k |
| Operating income | 1.9 m | 864.7 k | -69.2 k | 3.3 m | 311.3 k | 1.1 m | -86.0 k | -2.2 m |
| Depreciation & amortisation | 488.1 k ≈ | 529.8 k | 465.2 k | 494.9 k ≈ | 484.9 k ≈ | 520.7 k | 509.5 k | 562.9 k ≈ |
| Pre-tax income | 1.5 m | 721.8 k | -153.7 k | 3.2 m | 204.9 k | 54.7 k | -236.7 k | -2.3 m |
| Income tax | 367.6 k | -338.8 k | 110.4 k | 1.0 m | -181.7 k | -45.2 k | — | — |
| Net income | 611.9 k | 679.6 k | -277.7 k | 2.0 m | -503.4 k | -460.9 k | -241.4 k | -1.9 m |
| Diluted EPS | 0.05 | 0.05 ≈ | -0.02 | 0.15 | -0.04 | -0.03 ≈ | -0.02 | -0.15 |
| Operating cash flow | 2.5 m ≈ | -2.2 m | -544.3 k | 5.3 m ≈ | 2.0 m ≈ | -3.0 m | -1.8 m | 5.3 m ≈ |
| Capex | 1.2 m ≈ | 2.1 m | 354.1 k | 976.9 k ≈ | 2.0 m ≈ | 1.1 m | 2.2 m | 745.8 k ≈ |
| Dividends paid | 0 ≈ | 0 | — | — | 0 ≈ | 0 | — | — |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.8 m | 27.4 m | 31.4 m | 34.4 m | 45.8 m | 38.3 m | 38.2 m | 38.5 m |
| Revenue YoY | +15.1% | +53.9% | +14.5% | +9.6% | +33.2% | −16.4% | −0.2% | +0.7% |
| Net income | 2.5 m | 1.9 m | 3.0 m | 3.4 m | 7.0 m | 2.8 m | 3.0 m | 786.9 k |
| Net income YoY | +41.9% | −23.2% | +55.7% | +15.9% | +103.6% | −60.5% | +9.5% | −74.1% |
| Diluted EPS | unavailable | unavailable | unavailable | 0.28 | 0.56 | 0.22 | 0.24 | 0.06 |
| Diluted EPS YoY | unavailable | unavailable | unavailable | unavailable | +100.0% | −60.7% | +9.1% | −75.0% |
| net % | 14.0% | 7.0% | 9.5% | 10.0% | 15.3% | 7.2% | 7.9% | 2.0% |
| Free cash flow | -2.4 m | 538.6 k | 4.6 m | 3.8 m | -504.4 k | 1.1 m | 603.6 k | -591.7 k |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- unavailable USD
- Financial debt
- 4.4 m USD
- Net debt
- unavailable USD
- Equity
- 42.8 m USD
- Total assets
- 61.8 m USD
- Debt / equity
- 0.10x
- Current ratio
- 3.06x
- ROE
- 1.9%
- ROA
- 1.3%
- FCF margin
- -1.5%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 31.4 m | 34.4 m | 45.8 m | 38.3 m | 38.2 m | 38.5 m | SEC (XBRL)· 15 Apr 2026verified |
| Cost of revenue | 21.6 m | 23.0 m | 32.0 m | 27.9 m | 25.0 m | 26.0 m | SEC (XBRL)· 15 Apr 2026verified |
| Gross profit | 9.8 m | 11.4 m | 13.9 m | 10.4 m | 13.2 m | 12.5 m | SEC (XBRL)· 15 Apr 2026verified |
| Research & development | 81.4 k | 116.4 k | 99.3 k | 158.2 k | 330.0 k | 615.3 k | SEC (XBRL)· 15 Apr 2026verified |
| SG&A | — | — | — | — | 2.9 m | 3.6 m | SEC (XBRL)· 15 Apr 2026verified |
| Operating income | 4.1 m | 5.5 m | 7.1 m | 3.5 m | 5.5 m | 4.6 m | SEC (XBRL)· 15 Apr 2026verified |
| Depreciation & amortisation | 851.7 k | 965.9 k | 1.3 m | 1.7 m | 2.0 m | 2.0 m | SEC (XBRL)· 15 Apr 2026verified |
| EBITDA | 5.0 m ≈ | 6.4 m ≈ | 8.3 m ≈ | 5.2 m ≈ | 7.5 m ≈ | 6.6 m ≈ | SEC (XBRL)· 15 Apr 2026derived |
| Interest expense | 260.7 k | 199.9 k | 292.9 k | 498.7 k | — | — | SEC (XBRL)· 01 Apr 2024verified |
| Pre-tax income | 5.2 m | 6.7 m | 7.9 m | 3.6 m | 5.0 m | 3.3 m | SEC (XBRL)· 15 Apr 2026verified |
| Income tax | 1.6 m | 2.4 m | 145.9 k | -132.7 k | 851.2 k | 899.6 k | SEC (XBRL)· 15 Apr 2026verified |
| Net income | 3.0 m | 3.4 m | 7.0 m | 2.8 m | 3.0 m | 786.9 k | SEC (XBRL)· 15 Apr 2026verified |
| Diluted EPS | — | 0.28 | 0.56 | 0.22 | 0.24 | 0.06 | SEC (XBRL)· 15 Apr 2026verified |
| Weighted average diluted shares | 12.3 m | 12.5 m | 12.5 m | 12.5 m | 12.7 m | 13.6 m | SEC (XBRL)· 15 Apr 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 3.5 m | 5.7 m | 6.1 m | 5.0 m | 7.6 m | — | SEC (XBRL)· 31 Mar 2025verified |
| Receivables | 5.9 m | 7.1 m | 9.4 m | 9.8 m | 11.7 m | 12.6 m | SEC (XBRL)· 15 Apr 2026verified |
| Inventories | 8.4 m | 9.5 m | 14.4 m | 11.1 m | 10.9 m | 10.5 m | SEC (XBRL)· 15 Apr 2026verified |
| Current assets | 19.0 m | 23.8 m | 31.0 m | 30.2 m | 34.6 m | 32.9 m | SEC (XBRL)· 15 Apr 2026verified |
| Property, plant & equipment, net | 5.1 m | 4.9 m | 9.7 m | 13.2 m | 17.1 m | 16.1 m | SEC (XBRL)· 15 Apr 2026verified |
| Goodwill | 2.5 m | 2.5 m | 2.5 m | 2.5 m | 2.5 m | 2.5 m | SEC (XBRL)· 15 Apr 2026verified |
| Intangibles (excl. goodwill) | 2.8 m | 2.6 m | 2.4 m | 2.3 m | 2.1 m | 2.0 m | SEC (XBRL)· 15 Apr 2026verified |
| Total assets | 35.1 m | 39.6 m | 51.6 m | 55.5 m | 60.0 m | 61.8 m | SEC (XBRL)· 15 Apr 2026verified |
| Accounts payable | 558.1 k | 1.3 m | 873.9 k | 2.0 m | 2.0 m | 2.2 m | SEC (XBRL)· 15 Apr 2026verified |
| Short-term debt | 848.8 k | 793.6 k | 717.6 k | 59.5 k | 2.1 m | 397.0 k | SEC (XBRL)· 15 Apr 2026verified |
| Long-term debt | 3.0 m | 1.6 m | 5.4 m | 6.8 m | 6.6 m | 4.0 m | SEC (XBRL)· 15 Apr 2026verified |
| Current liabilities | 7.9 m | 9.8 m | 10.3 m | 10.1 m | 11.9 m | 10.8 m | SEC (XBRL)· 15 Apr 2026verified |
| Total liabilities | 11.3 m | 11.8 m | 16.3 m | 17.2 m | 18.6 m | 19.0 m | SEC (XBRL)· 15 Apr 2026verified |
| Equity | 23.8 m | 27.7 m | 35.2 m | 38.3 m | 41.4 m | 42.8 m | SEC (XBRL)· 15 Apr 2026verified |
Cash flow · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 5.7 m | 4.5 m | 1.5 m | 6.1 m | 5.6 m | 3.8 m | SEC (XBRL)· 15 Apr 2026verified |
| Capex | 1.1 m | 782.2 k | 2.0 m | 5.0 m | 5.0 m | 4.4 m | SEC (XBRL)· 15 Apr 2026verified |
| Free cash flow | 4.6 m ≈ | 3.8 m ≈ | -504.4 k ≈ | 1.1 m ≈ | 603.6 k ≈ | -591.7 k ≈ | SEC (XBRL)· 15 Apr 2026derived |
| Investing cash flow | -3.2 m | -659.5 k | -2.2 m | -4.9 m | -2.2 m | 890.9 k | SEC (XBRL)· 15 Apr 2026verified |
| Financing cash flow | -2.7 m | -1.7 m | 848.3 k | -379.9 k | -978.3 k | -5.9 m | SEC (XBRL)· 15 Apr 2026verified |
| Dividends paid | — | — | — | 626.8 k | 1.3 m | 1.3 m | SEC (XBRL)· 15 Apr 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
Risk
Valuation
olivLaw classification
- score weight coverage: 41.7% of at least 60%
- valuation methods computed: 0 of at least 1
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 80.1 m USD
Key indicators
Coverage and freshness
Score by group
42% · Insufficient data
Estimated value range
unavailable — no valuation method could be computed
Valuation assumptions are editorial choices, not measured; beta is not measured.
Valuation methods
- DCF (discounted cash flow)unavailable · the reported interest expense is far older than the latest period (the filer changed its XBRL tag): a stale figure is not used
- Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: P/Eunavailable · the base of the ratio is not positive
- Dividend discount (DDM)unavailable · input data missing
no valuation method could be computed
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 41.7% of at least 60%; valuation methods computed: 0 of at least 1
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | -8.8% | 29 (vs peers) | 15% |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | -5.6% | 0 (on a fixed band) | 20% |
| EPS CAGR 3Y · Growth | -52.5% | 0 (on a fixed band) | 20% |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | unavailable | unavailable | — |
| Current ratio · Balance sheet | 2.8x | 100 (on a fixed band) | 10% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | -4.3% | 0 (on a fixed band) | 20% |
| Shareholder yield (distributions) · Returns | 1.6% | 23 (on a fixed band) | 15% |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet· partial100/100 · 1/3 factors with a value
- Growth0/100 · 2/2 factors with a value
- Quality· partial29/100 · 1/3 factors with a value
- Returns· partial23/100 · 1/2 factors with a value
- Valuation· partial0/100 · 1/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
FLEXIBLE SOLUTIONS INTERNATIONAL, INC (FSI). Latest full fiscal year: 2025; data up to 2026-06-30.
Figures computed from the financial statements: revenue 38.5 m USD in 2025; YoY growth 0.7%; net margin -8.8%; ROE -8.2%.
Valuation cannot be computed from the available data.
Insufficient data for a verdict (score weight coverage: 41.7% of at least 60%; valuation methods computed: 0 of at least 1).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Current ratio: 2.8x
What contradicts it
- Net margin: -8.8%
- Revenue CAGR 3Y: -5.6%
- EPS CAGR 3Y: -52.5%
- FCF yield: -4.3%
- Shareholder yield (distributions): 1.6%
Not assessed (insufficient data or a ratio without meaning): ROIC, FCF conversion, Net debt / EBITDA, Interest coverage, P/E (TTM), EV/EBITDA, Payout ratio (FCF).
Versus the vertical median
Miscellaneous Chemical Products (SIC 2890) · same industry (4-digit SIC) · compared with 7 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| ESIElement Solutions Inc | 8.1 bn | 39.6 | 7.4% | 5.9% | +3.8% | +29% / +60% |
| CBTCabot Corp | 3.9 bn | 21.1 | 12.1% | 5.2% | −7.0% | +20% / −1% |
| WDFCWd-40 Company | 3.1 bn | 38.3 | 30.4% | 12.0% | +11.0% | +19% / −4% |
| FTKFlotek Industries Inc | 895.4 m | 25.0 | 37.8% | 13.0% | +26.9% | +73% / +685% |
| OECOrion S.A. | 331.8 m | — | -8.1% | -1.8% | −3.8% | +16% / −75% |
| ASPIASP Isotopes Inc. | 292.8 m | — | -80.9% | -380.3% | +475.5% | −69% / −1% |
| ARQArq, Inc. | 81.8 m | — | -25.0% | -38.5% | +10.4% | −50% / −31% |
| FSIFlexible Solutions International, Inc | 80.1 m | — | -8.2% | -8.8% | +0.7% | −29% / +227% |
1- and 3-year price returns: for FSI from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 3 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 5 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
In brief
Flexible Solutions International makes biodegradable polymers, water-treatment specialty chemicals and food-grade products used in the oil, agriculture and swimming pool industries. The company depends heavily on a small number of customers, and in 2026 its sales mix shifted as a new Panama plant and food-grade customer came online, with three primary customers accounting for 54% of sales in the June 2026 quarter 2.
SWOT
Strengths
- A biodegradable polymer portfolio with uses across several industries, which reduces dependence on a single sector 12.
- Internal funding capacity, with positive working capital and substantial operating cash flow in fiscal 2025 1.
- International presence, with sales outside the United States forming a meaningful share of revenues 1.
Weaknesses
Opportunities
- Expansion of food-grade production and the new Panama plant could diversify revenues if volumes grow 2.
- Demand for water and energy conservation solutions could grow in drought-affected regions 13.
- The license granted under the June 2026 settlement could open sales in Latin America and the Caribbean 2.
Risks
- Dependence on large customershigh
A small number of customers generate a significant share of sales, and losing one could substantially reduce revenues 12.
- Operating losseshigh
The company has had operating losses and negative operating cash flow in the past, and profitability in future periods is not assured 1.
- Raw material supplymedium
The lack of long-term supply contracts could lead to interruptions that affect results 1.
- Environmental and regulatory riskmedium
Chemical products are subject to strict environmental rules, and failure to comply could lead to fines or changes in production 1.
- International exposuremedium
Sales abroad expose the company to currency fluctuations, political change and delays in customer payments 1.
Investment thesis
What would need to be true (bull case)
- If the Panama plant and food-grade production reach steady volumes, the company could recover margins and reduce its dependence on large customers 2.
- The June 2026 settlement could open markets in Latin America and the Caribbean, and a diversified product range could stabilise revenues 2.
- The company reported positive working capital and said it has sufficient resources for coming commitments, which could support investment 1.
What would break the thesis
- If sales remain concentrated in a few customers, the loss of one could reduce revenues significantly 12.
- Sales of some products declined in fiscal 2025 and in the first half of 2026, and delays at Panama could prolong the recovery 2.
- Tariffs and crude oil price volatility could compress margins, and the history of losses shows profitability is not assured 1.
What to watch
- Recovery of SPCH sales after Panama delaysQ3 2026
- Gross margin trend as food-grade production scalesQ3 2026
- Share of sales from the three primary customersnext 10-Q
- Impact of tariffs on the cost of aspartic acid imported from China2027
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
The business
Flexible Solutions International, Inc. develops, manufactures and markets biodegradable polymers (TPA) made from aspartic acid, used by the petroleum, chemical, utility and mining industries to prevent corrosion and scaling in water piping 1. The range also includes nitrogen conservation products for agriculture and food-grade products made for specific clients, sold through the SPCH and FGPI divisions 2. In fiscal 2025 sales of EWCP and TPA products declined on lower customer orders, and sales outside the United States were approximately 16% of revenues 1.
The company is based in Victoria, British Columbia, with production including a Peru, Illinois location and a new Panama facility 23. Revenues are sensitive to crude oil prices, which affect the cost of aspartic acid imported from China, and to oil and gas activity and drought, since TPA products are also sold to farmers 1.
Segments
SPCH (specialty chemicals)
Includes TPA biodegradable polymers, nitrogen conservation products for agriculture, and the EWCP chemical for swimming pools and reservoirs that slows water evaporation 2. In the first half of 2026, SPCH sales fell partly due to a delay at the new Panama facility and lower sales to a former equity investee 2.
Market context
The company sells into the petroleum, chemical, mining, agriculture and swimming pool industries, and demand depends on oil and gas activity, drought conditions and crude oil prices 12. Seasonality is low for TPA, but pool product sales rise in summer, so sales from January to June are usually higher than from July to December 1.
Tariffs on raw materials imported from China are an uncertainty factor, and the company has no long-term supply contracts with its suppliers 12.
Trends
- Tariffs on imports from Chinaheadwind
Aspartic acid imported from China is a key ingredient in TPA, so higher tariffs could lead to price increases for customers if relief is not available 12.
- Oil and gas industry activitymixed
Demand for TPA products depends on oil and gas company activity, so lower activity could reduce orders 12.
- Panama expansion and food-grade productsmixed
The new Panama plant and food-grade production could support higher volumes, but in the short term they brought startup costs and lower margins 2.
- Drought and agricultural usemixed
Drought conditions could raise demand for water and nitrogen conservation products, but they can also reduce farmer activity 1.
Competitive position
The sources do not name any competitors. The company notes that competitive pressures can lower selling prices and that competitors' new product launches can affect sales 1.
Intellectual property protection is limited in some areas, which allows competitors to copy certain products, processes and technologies 1.
- Unnamed specialty chemical producers
The sources do not name competitors; the company refers only to price pressure and rivals' new product launches 1.
- Biodegradable polymer producers
Competition may come from firms offering biodegradable alternatives for the same industrial and agricultural uses 1.
- Swimming pool product suppliers
Competition for evaporation-reduction products for pools is not described in the sources 1.
- Contract food-ingredient producers
The FGPI segment serves confidential clients, and competition in this area is not specified in the sources 2.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
No news in our archive over the last 180 days.
SEC filings
- Proxy statement07 Oct 2026
- Current report01 Sept 2026Departure or appointment of officers · Other events · Financial statements and exhibits
- Current report18 Aug 2026Other events · Financial statements and exhibits
- Quarterly report14 Aug 2026
- Current report01 Jul 2026Material agreement · Financial statements and exhibits
- Current report08 Jun 2026Item 4.01 · Financial statements and exhibits
- Current report18 May 2026Other events · Financial statements and exhibits
- Quarterly report15 May 2026
- Current report20 Apr 2026Other events · Financial statements and exhibits
- Annual report15 Apr 2026
Sources
- [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / Flexible Solutions International, Inc. · 15 Apr 2026
- [2] Form 10-Q, quarter ended 2026-06-30 · SEC / Flexible Solutions International, Inc. · 14 Aug 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / Flexible Solutions International, Inc. · 25 Apr 2024
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.